Top Page
Home Consortium Ltd
(Sydney:HMC)
Home Consortium Ltd (HMC) vs. iShares MSCI Australia ETF (EWA)
Home Consortium Ltd Business Overview & Revenue Model
Home Consortium Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 234.20M | 249.20M | 81.40M | 69.53M | 78.69M | 69.80M |
| Gross Profit | 234.20M | 234.20M | 81.10M | 44.56M | 64.34M | 46.37M |
| EBITDA | 87.50M | 91.90M | 147.70M | 19.04M | 42.99M | 4.49M |
| Net Income | 147.30M | 147.30M | 66.00M | 57.10M | 77.25M | -54.50M |
Balance Sheet | ||||||
| Total Assets | 2.18B | 2.18B | 1.79B | 1.34B | 912.95M | 982.41M |
| Cash, Cash Equivalents and Short-Term Investments | 665.30M | 665.30M | 247.30M | 115.67M | 57.55M | 11.69M |
| Total Debt | 138.10M | 138.10M | 202.00M | 89.98M | 4.34M | 255.24M |
| Total Liabilities | 299.20M | 299.20M | 281.00M | 144.42M | 66.95M | 271.43M |
| Stockholders Equity | 1.66B | 1.66B | 1.22B | 1.03B | 846.00M | 706.89M |
Cash Flow | ||||||
| Free Cash Flow | 38.60M | -15.90M | 69.60M | 34.06M | 15.19M | 25.78M |
| Operating Cash Flow | 47.20M | 31.00M | 69.60M | 34.06M | 18.53M | 25.78M |
| Investing Cash Flow | -179.40M | -98.40M | -161.70M | -254.03M | 319.50M | -154.21M |
| Financing Cash Flow | 37.30M | 1.70M | 298.70M | 211.19M | -292.17M | 110.55M |
Home Consortium Ltd Technical Analysis
Home Consortium Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | AU$2.81B | 11.19 | 8.25% | 6.13% | 2.70% | 205.08% | |
75 Outperform | AU$1.34B | 8.81 | 10.22% | 3.35% | 206.14% | 101.96% | |
72 Outperform | AU$2.27B | 17.65 | 8.27% | 1.96% | 6.96% | 815.99% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
57 Neutral | AU$1.09B | 41.69 | 1.70% | 7.05% | 4.69% | ― | |
53 Neutral | AU$695.90M | -35.20 | -1.91% | 8.63% | -4.50% | 88.28% | |
46 Neutral | AU$662.51M | -3.39 | -26.73% | ― | -38.91% | -453.73% |
Home Consortium Ltd Corporate Events
HMC Capital Limited has announced a change in the interests of its director, Gregory Hayes. The update reveals that Hayes has been granted 15,692 rights to acquire fully paid ordinary shares under the Non-Executive Director Equity Plan, in lieu of board fees for the fiscal year 2026. This adjustment increases his direct interest in rights to acquire shares, potentially impacting his influence within the company and aligning his interests with the company’s performance.
HMC Capital Limited has announced a change in the director’s interest notice concerning Fiona Pak-Poy. The change involves the grant of 15,692 rights to acquire fully paid ordinary shares in lieu of board fees for the fiscal year 2026 under the Non-Executive Director Equity Plan. This move reflects the company’s strategy to align director compensation with shareholder interests, potentially impacting the company’s governance and financial strategies.
HMC Capital Limited has announced a change in the director’s interest notice, specifically regarding Susan Roberts. The change involves the granting of 19,972 rights to acquire fully paid ordinary shares in lieu of board fees for the fiscal year 2026 under the Non-Executive Director Equity Plan. This adjustment reflects the company’s approach to compensating its board members and may influence stakeholders’ perceptions of the company’s governance and compensation strategies.
HMC Capital Limited, listed on the ASX, has announced a change in the director’s interest notice for Christopher Roberts. The update details the acquisition of 17,120 rights to acquire fully paid ordinary shares as part of the Non-Executive Director Equity Plan for FY26, and the expiry of 10,000 listed options previously granted to early investors. This change reflects the company’s ongoing management of director equity and investor relations, potentially impacting its governance and shareholder engagement strategies.
HMC Capital Limited, listed on the ASX, has announced a change in the director’s interest notice involving Christopher Saxon. The notice details the acquisition of 35,666 rights to acquire fully paid ordinary shares as part of the Non-Executive Director Equity Plan, in lieu of board fees for FY26, and the expiry of 4,000 listed options previously granted to early investors. This change reflects adjustments in the director’s holdings, potentially impacting the company’s governance and stakeholder interests.
HMC Capital Limited, listed on the ASX, has announced a change in the director’s interest notice for David Anthony Di Pilla. The notice details the direct and indirect interests held by Di Pilla across various entities, including trusts and companies he controls. This update reflects changes in the number of securities held by these entities, which could impact the company’s governance and shareholder dynamics.
HMC Capital Limited has announced the issuance of 743,071 performance rights as part of an employee incentive scheme. These unquoted securities are not intended to be listed on the ASX, reflecting the company’s strategy to motivate and retain its workforce, which may impact its operational efficiency and stakeholder engagement.
HMC Capital Limited has announced the issuance of 125,542 unquoted securities under the ASX security code HMCAB, with the issue date set for November 27, 2025. This issuance is part of an employee incentive scheme and is not intended to be quoted on the ASX, indicating a strategic move to motivate and retain employees, potentially impacting the company’s operational dynamics and stakeholder interests.
HMC Capital Limited announced the results of its 2025 Annual General Meeting, where all resolutions were passed except for the election of a non-board endorsed director candidate, Stephen Mayne. The successful resolutions, including the re-election of a director and the issuance of performance rights, reflect the company’s ongoing strategic priorities and governance practices, potentially reinforcing its market position and investor confidence.
HMC Capital held its 2025 Annual General Meeting, where the Chair and CEO addressed shareholders, outlining key aspects of the company’s 2025 results and business updates. The meeting agenda included the adoption of the Remuneration Report, re-election of Gregory Hayes as Director, granting of Performance Rights to CEO David Di Pilla, and renewal of takeover bid provisions. A nomination for Stephen Mayne as Director was also considered, with the Board recommending against his election. Voting results will be released to the ASX post-meeting.
HMC Capital Ltd has secured commitments from existing lenders to extend and increase its revolving debt facility from $675 million to $715 million, with the maturity date now set for November 2027. This move is aimed at supporting HMC’s strategic initiatives and maintaining a strong balance sheet, reflecting lender confidence in its business model and aiding in the execution of its funds management strategy, particularly in the energy transition sector.
HMC Capital Limited announced an update regarding the expiry of its listed options, which will now cease trading on the ASX at the close of business on Monday, 24 November 2025, due to the original expiry date falling on a non-business day. This adjustment ensures clarity for stakeholders and maintains the company’s commitment to transparent communication.
HMC Capital Limited announced the upcoming expiry of its listed options (ASX: HMCO) on 30 November 2025. Option holders can choose to exercise their options at $7.00 per share, sell them before the official quotation ceases on 25 November 2025, or let them expire. This announcement is crucial for stakeholders as it impacts their investment decisions and the company’s capital structure.
HMC Capital Limited has announced its 2025 Annual General Meeting, scheduled for November 19, 2025, at their Sydney location. The company has emphasized its commitment to environmentally sustainable practices by discontinuing the distribution of hard copy meeting materials, encouraging shareholders to opt for digital communications. This move reflects HMC Capital’s ongoing efforts to align its operations with sustainable practices, potentially enhancing its reputation among environmentally conscious investors.
HMC Capital Limited has announced its Annual General Meeting (AGM) for shareholders, scheduled to take place in person on November 19, 2025, in Sydney. The company encourages shareholders to attend or appoint a proxy to vote on their behalf, with proxy forms due by November 17, 2025. This meeting is an opportunity for shareholders to engage with the company’s strategic direction and performance, reflecting its commitment to transparency and stakeholder engagement.
HMC Capital Limited has released its Annual Report for the year ended 30 June 2025. The report highlights the company’s continued focus on managing a diverse portfolio of assets and its ability to execute complex transactions, which has supported its rapid growth in funds under management and strong returns for investors.
HMC Capital Limited has announced the issuance of 5,439,130 unquoted equity securities in the form of options, as part of an employee incentive scheme. This move is likely aimed at enhancing employee retention and motivation, potentially impacting the company’s operational efficiency and market competitiveness.
HMC Capital Limited, listed on the ASX under the ticker HMC, announced a change in the director’s interest, specifically concerning David Anthony Di Pilla. This change involves various trusts and entities controlled by Di Pilla, reflecting his indirect and direct interests in the company’s securities. The announcement highlights the intricate structure of shareholding and control within the company, which may impact perceptions of governance and stakeholder interests.
HMC Capital Limited has announced the cessation of 498,752 performance rights due to the lapse of conditional rights which could not be satisfied. This announcement may impact the company’s capital structure and could have implications for stakeholders who were anticipating the fulfillment of these conditions.
HMC Capital Limited has announced that its 2025 Annual General Meeting will be held on November 19, 2025, with further details to be provided in the official notice. This meeting is a key event for stakeholders, as it includes the election of directors, with nominations closing on October 8, 2025, potentially impacting the company’s governance and strategic direction.
HMC Capital Limited has announced a change in the director’s interest notice for David Anthony Di Pilla. The notice details various entities through which Di Pilla holds direct and indirect interests in the company, including trusts and companies he controls. The change in interests reflects adjustments in the number of fully paid ordinary shares held by these entities, impacting the company’s governance and potentially influencing shareholder dynamics.